DROXIA 6337 (Droxia 400 MG)
Generic Name: hydroxyurea
This pill with imprint "DROXIA 6337" is Orange, Capsule-shape and has been identified as Droxia 400 MG. It is manufactured by Bristol-Myers Squibb.
Droxia is used in the treatment of chronic myelogenous leukemia; anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 400 MG is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- hydroxyurea
- Imprint:
- DROXIA 6337
- Strength:
- 400 MG
- Color:
- Orange
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-6337
- Inactive Ingredients:
- citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
D&C Yellow No. 10
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antimetabolites
Consumer resources
Other brands: Hydrea
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
